Omija fruit ethanol extract improves adiposity and related metabolic disturbances in mice fed a high-fat diet |
| |
Affiliation: | 1. Department of Food Science and Nutrition, Kyungpook National University, 1370 Sankyuk Dong Puk-ku, 702-701 Daegu, Republic of Korea;2. Food R&D, CJ Cheiljedang Corp, 152-051 Seoul, Republic of Korea;3. School of Life Sciences and Biotechnology, Kyungpook National University, 1370 Sankyuk Dong Puk-ku, 702-701 Daegu, Republic of Korea;4. Department of Food Science and Nutrition, Pukyong National University, 45 Yongso-ro, Nam-gu, 48513 Busan, Republic of Korea;1. Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, P.O. Box: 14115-111, Tehran, Iran;2. Endocrine Division, Vali-asr Hospital, Tehran University of Medical Sciences, P.O. Box: 14197-33147, Tehran, Iran |
| |
Abstract: | This study investigated the biological and molecular mechanisms underlying the antiobesity effect of omija fruit ethanol extract (OFE) in mice fed a high-fat diet (HFD). C57BL/6J mice were fed an HFD (20% fat, w/w) with or without OFE (500 mg/kg body weight) for 16 weeks. Dietary OFE significantly increased brown adipose tissue weight and energy expenditure while concomitantly decreasing white adipose tissue (WAT) weight and adipocyte size by up-regulating the expression of brown fat-selective genes in WAT. OFE also improved hepatic steatosis and dyslipidemia by enhancing hepatic fatty acid oxidation-related enzymes activity and fecal lipid excretion. In addition to steatosis, OFE decreased the expression of pro-inflammatory genes in the liver. Moreover, OFE improved glucose tolerance and lowered plasma glucose, insulin and homeostasis model assessment of insulin resistance, which may be linked to decreases in the activity of hepatic gluconeogenic enzymes and the circulating level of gastric inhibitory polypeptide. These findings suggest that OFE may protect against diet-induced adiposity and related metabolic disturbances by controlling brown-like transformation of WAT, fatty acid oxidation, inflammation in the liver and fecal lipid excretion. Improved insulin resistance may be also associated with its antiobesity effects. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|